Midori Shima Selected Research

Lupus Coagulation Inhibitor (Lupus Anticoagulant)

6/2021	Inhibitor Index in the Clot Waveform Analysis-Based Mixing Test Differentiates among Hemophilia A without and with Inhibitors, and Lupus Anticoagulant.
4/2013	Lupus anticoagulant hypoprothrombinemia syndrome in Bence-Jones protein κ-type multiple myeloma patient with phosphatidylserine-dependent antiprothrombin antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Midori Shima Research Topics

Disease

110	Hemophilia A (Haemophilia) 01/2024 - 03/2002
59	Hemorrhage 12/2023 - 03/2004
21	Thrombosis (Thrombus) 06/2023 - 06/2002
7	Hemophilia B (Haemophilia B) 01/2022 - 05/2008
7	Thrombotic Microangiopathies 03/2021 - 09/2016
5	Metrorrhagia (Spotting) 10/2023 - 01/2017
3	Pain (Aches) 11/2023 - 01/2007
3	Disease Progression 03/2023 - 01/2020
3	Type 3 von Willebrand Disease 09/2022 - 03/2006
3	Type 2 von Willebrand Disease 03/2021 - 03/2020
3	Myocardial Infarction 01/2021 - 09/2010
3	Disseminated Intravascular Coagulation 09/2020 - 06/2018
3	Joint Diseases (Joint Disease) 01/2019 - 06/2011
3	Body Weight (Weight, Body) 01/2018 - 11/2009
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2016 - 05/2008
3	Venous Thrombosis (Deep-Vein Thrombosis) 07/2013 - 05/2010
2	Inflammation (Inflammations) 12/2023 - 07/2019
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 09/2023 - 01/2020
2	Thrombasthenia (Glanzmann Thrombasthenia) 06/2023 - 02/2021
2	Infections 03/2023 - 11/2014
2	Human Influenza (Influenza) 01/2023 - 09/2016
2	Sepsis (Septicemia) 09/2020 - 02/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 07/2014
2	Thromboembolism 01/2020 - 01/2019
2	Purpura 06/2019 - 12/2013
2	von Willebrand Diseases (von Willebrand's Disease) 05/2019 - 02/2015
2	Neoplasms (Cancer) 06/2018 - 01/2017
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2017 - 01/2017
2	Thrombophilia 01/2017 - 06/2013
2	Hyperplasia 11/2009 - 12/2008
1	Lung Injury 12/2023
1	Factor VII Deficiency (Hypoproconvertinemia) 06/2023
1	Musculoskeletal Abnormalities 06/2023
1	Infectious Mononucleosis (Glandular Fever) 03/2023
1	Communicable Diseases (Infectious Diseases) 01/2023

Drug/Important Bio-Agent (IBA)

59	Factor VIII (Coagulation Factor VIII)IBA 12/2023 - 03/2002
42	emicizumabIBA 01/2024 - 11/2014
20	Hemostatics (Antihemorrhagics)IBA 06/2023 - 01/2004
16	von Willebrand FactorIBA 12/2023 - 03/2004
13	Thrombin FDA Link 02/2022 - 10/2009
11	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2022 - 05/2008
11	Blood Coagulation Factors (Coagulation Factor)IBA 01/2021 - 01/2007
10	FibrinIBA 03/2021 - 10/2009
9	AntibodiesIBA 09/2022 - 03/2004
8	Thromboplastin (Tissue Factor)IBA 02/2021 - 10/2009
7	AutoantibodiesIBA 01/2020 - 02/2006
6	recombinant FVIIa (rFVIIa)FDA Link 06/2023 - 01/2004
6	AnticoagulantsIBA 01/2023 - 06/2013
6	prothrombin complex concentrates (PPSB)IBA 03/2021 - 01/2007
6	Prothrombin (Factor II)IBA 01/2021 - 04/2009
5	CoagulantsIBA 03/2023 - 01/2020
5	Fibrinolysin FDA Link 02/2022 - 07/2017
5	Monoclonal AntibodiesIBA 01/2021 - 10/2017
4	Neutralizing AntibodiesIBA 11/2023 - 06/2013
4	Immunoglobulin G (IgG)IBA 09/2022 - 03/2004
4	Factor IXa (Coagulation Factor IXa)IBA 01/2020 - 11/2014
4	AntigensIBA 07/2019 - 08/2003
3	Heme (Haem)IBA 09/2021 - 01/2019
3	Factor VIIIaIBA 03/2021 - 01/2017
3	Dacarbazine (DIC)FDA LinkGeneric 09/2020 - 06/2018
3	Factor X (Stuart Factor)IBA 01/2020 - 06/2013
3	Factor VIIa (Activated Factor VII)IBA 01/2020 - 09/2003
3	Ellagic AcidIBA 01/2020 - 12/2009
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2012
3	Protein CIBA 10/2018 - 06/2013
3	Therapeutic UsesIBA 01/2018 - 07/2008
3	Protein SIBA 01/2017 - 06/2013
3	IsoantibodiesIBA 05/2016 - 02/2006
2	fitusiranIBA 01/2023 - 01/2019
2	Bispecific AntibodiesIBA 01/2022 - 05/2020
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 06/2021 - 04/2013
2	CollagenIBA 02/2021 - 03/2020
2	Asparaginase (Elspar)FDA Link 01/2020 - 01/2017
2	AntithrombinsIBA 01/2017 - 06/2013
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2014 - 10/2009
2	Factor V (Coagulation Factor V)IBA 12/2013 - 01/2011
2	argatroban (MPQA)FDA Link 07/2013 - 10/2009
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 07/2013 - 05/2010
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2012 - 05/2008
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2011 - 08/2003
2	Benzene (Benzole)IBA 11/2009 - 12/2008
2	Ethanol (Ethyl Alcohol)IBA 10/2009 - 09/2006
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	LipopolysaccharidesIBA 12/2023
1	Factor VII (Proconvertin)IBA 06/2023
1	COVID-19 VaccinesIBA 01/2023
1	VaccinesIBA 01/2023
1	concizumabIBA 01/2023
1	marstacimabIBA 01/2023

Therapy/Procedure

42	Therapeutics 11/2023 - 08/2003
5	Transplantation 03/2021 - 05/2005
5	Injections 05/2019 - 10/2012
2	Operative Surgical Procedures 10/2023 - 06/2023
2	Arthrodesis 08/2018 - 06/2011
2	Central Venous Catheters 01/2017 - 09/2016
2	Intravenous Infusions 05/2016 - 06/2015
2	Ligation 02/2016 - 05/2010
2	Tooth Extraction (Tooth Extractions) 12/2015 - 03/2006
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2023
1	Platelet Transfusion (Blood Platelet Transfusions) 06/2023